Download Antibiotics Workshop

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Toxicodynamics wikipedia , lookup

DNA-encoded chemical library wikipedia , lookup

Ofloxacin wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Discovery and development of integrase inhibitors wikipedia , lookup

Antibiotics wikipedia , lookup

Discovery and development of cephalosporins wikipedia , lookup

Transcript
Antibiotics
Learning Outcomes
•
•
•
•
•
•
•
•
•
•
•
Understand the causes of infections
Know about the Classification of Antibacterial agents
Understand what Factors guide Antibiotic Choice
Know and understand key concepts about the following
antibiotics:
Penicillins
Cephalosporins
Macrolides
Tetracyclines
Aminoglycosides
Quinolones
Metronidazole
Definitions
• Antibiotic, antibacterial, antimicrobial, antiinfectives, anti-fungals, anti-virals
• BNF classification
• Natural, semi synthetic and synthetic
Importance
• Host immune system
• Resistance
Causes of infections
•
•
•
•
•
3 types of micro-organisms:
Bacteria
Fungi
Viruses
Give an example of a disease caused by
each of the above
Identification of Bacterial
Organisms
• Gram staining is a basic microbiologic procedure for
detecting and identification of bacteria.
• The main structural component of cell wall is
peptidoglycan.
• Peptidoglycan and cell wall structural differences form
the basis of the different staining properties.
• With Gram staining:
– Gram +ve stain purple
– Gram –ve stain pink
• Why is Gram staining important?
• Cell shapes(cocci/rods)
• Aerobic/anaerobic
Gram Positive and Negative
organisms
• What is a Gram stain?
• Gram positive organisms:
– Staphylococcus aureus (cocci)
– Streptococcus pneumoniae (diplcocci)
– Coagulase negative staphylococcus (cocci)
• Gram negative organisms:
–
–
–
–
–
Escherichia coli (rods)
Klebsiella pneumoniae
Pseudomonas aerguinosa
Salmonella typi (rods)
Neisseria meningitidis (diplococci)
Factors guiding Antibiotic
Choice
–
–
–
–
–
The presumed site of infection
Positive microbiological culture results
Suspected or known organisms
Resistance patterns of the common microbial flora.
Properties of the antibiotic: e.g. route of
administration, pharmacokinetic aspects
– Patient’s health status:
e.g. immune status (especially neutropenia and
immunosuppressive drugs), allergies, renal
dysfunction, and hepatic dysfunction
Choosing An Antibiotic
•
•
•
•
•
Cost
Local resistance
Environment
Patient factors
Site
Choosing An Antibiotic
• BACTERIAL FACTORS
- Use only for bacterial infections
- Identify bacteria involved, or best guess
HOST FACTORS
- site, route, allergies, renal function, hepatic
function, pregnancy
DRUG FACTORS
- activity, site,bactericidal/bacteriostatic route, cost
Classification of Antibacterial
agents
•
main ways:
–
–
–
–
•
Whether they are bacteriostatic or bactericidal
By target site
By chemical structure
Bacterial spectrum
targets for antibacterials:
–
–
–
–
Cell wall synthesis
Protein synthesis
DNA synthesis
Metabolic pathways
Selective Toxicity
• Kill/harm micro-organism without harming
host organism
• Antibiotics-> high therapeutic index
• TI = toxic dose/therapeutic dose
Aspects of antibiotics
• Method of action –
bactericidal/bacteriostatic
• Spectrum of activity
- Broad
- Narrow
Penicillins
• Bactericidal agents
• Contain a β-lactam ring in structure.
• They inhibit synthesis of the bacterium cell wall by
affecting synthesis of peptidoglycan.
• Peptidoglycan cell wall surrounds certain bacteria and is
essential for their survival.
• This results in dividing cells not being able to maintain
the osmotic gradient.
• Net effect is cell swelling, rupture and death of the
bacterium.
Penicillins
• Spectrum:
– Aerobic Gram +ve
– Gram –ve cocci
– Many anaerobic micro-organisms
– Not all penicillins are considered broad
spectrum antibiotics
Benzylpenicillin or Penicillin G
• Very poor oral absorption
• Given IV or IM (single doses > 1.2g IV
route only)
• High Na+ content 1.68mmol/600mg vial,
3.36mmol/3.2g vials.
• Slow IV injection or infusion over 30-60
minutes.
Benzylpenicillin
• Unwanted effects:
– Allergic reaction in up to 10% of exposed individuals
– Anaphylaxis less common in 0.05%
– Immediate anaphylaxis, urticaria, rash after penicillin
administration should not receive penicillin.
– Minor rash >72 hrs after exposure is probably not a true allergy
– Those allergic to one penicillin are allergic to all
• Elimination:
– Renal excretion
– Rapid, short half life
– Dose reduced in severe renal impairment
Amoxicillin/Ampicillin
• Broad spectrum
• Use e.g. community acquired respiratory tract
infections- H Influenza and S. Pneumoniae
• Renal excretion
• Amoxicillin preferred oral route
Co-amoxiclav
• Consists of amoxicillin combined with a betalactamase inhibitor clavulanic acid
• Spectrum:
– Active against Gram-ve rods resistant to amoxicillin
due to beta-lactamases
– E.g. resistant strains of E.coli, S. aureus and H.
influenzae.
– Clavulanic acid has no antibacterial activity
Flucloxacillin
•
•
•
•
Bactericidal antibiotic
A beta-lactamase-resistant penicillin
Used for penicillin-resistant staphylococci.
Can be less effective against bacterium that
does not produce beta-lactamase
• It is less active against Streptococcus
pneumoniae and Str. pyogenes than penicillin.
Flucloxacillin
• IV dose: 0.25-2g every 6 hours
• Elimination:
– Mainly renally excreted as unchanged drug
– Small extent of metabolism
• Unwanted effects:
– Hypersensitivity as in penicillin
– Hepatitis & cholestatic jaundice were reported several weeks
after treatment was stopped.
– Risk factor are increasing age and > 2weeks treatment.
Cephalosporins
• Bactericidal agents
• Semi-synthetic antibiotics, related to penicillins
and contain β-lactam ring.
• Some are susceptible to β-lactamase activity, so
less activity against staphylococcal infections.
• β-lactamase are enzymes that catalyse the
hydrolysis of beta-lactam, resulting in loss of
antibacterial activity.
Cephalosporins
• 1st, 2nd 3rd generation
• Mostly given IV, IM, except cefalexin(1st gen.) and
cefuroxime(2nd gen.)
• They distribute into many tissues.
• Spectrum:
– Second line in many infections
– Broad spectrum antibiotics
– Generally 3rd generations have higher activity against Gram –ve
bacterium, but less activity against Gram +ve ones.
Cephalosporins
• Unwanted effects:
– Hypersensitivity reactions.
– 10% of penicillin-sensitive patients are also allergic to
cephalosporins
– 2nd & 3rd generation higher risk of infection with
Clostridium difficile
• Elimination:
– Mainly renal via tubular secretion
– Some like 40% ceftriaxone in bile
Macrolides
• E.g. erythromycin, clarithromycin.
• Similar antibacterial spectrum to penicillins
• Mechanism: inhibit bacterial protein synthesis by
binding to bacterial ribosome.
• Bacteriostatic
• Can be effective against unusual organisms
Macrolides
• Generally safe drugs
• Erythromycin can cause gastrointestinal
problems which are less common with other
agents.
• Azithromycin has a long half life
• Macrolides can inhibit cytochrome P450 leading
to accumulation of drugs.
Tetracyclines
• E.g. tetracycline, doxcycline
• Mechanism inhibit protein synthesis
• Absorption of tetracyclines is affected by calcium and
magnesium ions, food and iron preparations.
• Broad spectrum antibiotics
• Bacteriostatic
• Should be avoided in pregnancy, breast feeding and
children under 12 years as they bind to calcium in
growing bones and teeth causing discoloration.
Aminoglycosides
• These include: gentamicin, streptomyocin,
, neomycin.
• They resemble each other in:
– Antibacterial activity
– Pharmacokinetic properties
– toxicity
Aminoglycosides
• Mechanism:
– Bactericidal activity
– Inhibit bacterial protein synthesis
– They do this by binding to the 30S ribosomal
subunit.
– They stop the translation of mRNA into the
proteins.
Aminoglycosides
• Spectrum:
–
–
–
–
Many Gram-ve (Including Pseudomonas)
Some Gram+ve
Inactive against anaerobes
Used in serious Gram –ve infections in combination
with agents that disrupt cell wall synthesis (e.g.
penicillin)
– Synergistic effect with penicillin
– Not absorbed orally so only given IM or IV.
Aminoglycosides
• Elimination:
– Renally by glomerular filtration
– In renal impairment accumulation occurs
rapidly
– Result is an increase in toxicity (ototoxicity
and nephrotoxicity)
– Dose adjustment is essential in renal
impairment
Aminoglycosides
• Unwanted effects:
– Serious effects that are dose related.
• Ototoxicity:
– Progressive damage to sensory cells
– Result can be irreversible: vertigo, loss of balance,
auditory disturbances, deafness.
– Effect is increased by ototoxic drugs e.g. loop
diuretics.
Aminogylcosides
• Nephrotoxicity:
– Due to damage to kidney tubules which can be
reversed by stopping the drug
– Risk factors:
• Pre-existing renal damage
• Reduced urine output
• Concomitant use of nephrotoxic drugs (administer far apart if
possible)
• elderly
• Monitoring of plasma levels is necessary
Quinolones
• These include ciprofloxacin, levofloxacin.
• Spectrum of activity may differ between agents.
• Active against aerobic G – but not active against
anaerobes
• Use: prostate, UTI, respiratory
• Mechanism:
–
–
–
–
Bactericidal
Inhibition of replication of bacterial DNA
They block the action of the enzyme DNA gyrase.
DNA gyrase is responsible for forming DNA supercoils for
replication and repair.
Quinolones
• Elimination
– Hepatic metabolism
– Renal excretion
• Unwanted effects
– CNS effects: dizziness, headache, tremor,
convulsions.
– Tendon pain and inflammation, damage and rupture,
especially in elderly and concomitant use of
corticosteroids.
– Drug interactions with many agents
Metronidazole
• Spectrum
– Bactericidal activity
– Active against anaerobic bacteria & protozoa
– Inhibit DNA synthesis and breaks down
existing DNA
Metronidazole
• Used IV, oral and rectal.
• Elimination:
– Metabolised by the liver
• Unwanted effects;
– Nausea and vomiting
– Metallic taste
– Disulfiram-like reaction when taken with alcohol
Trimethoprim
•
•
•
•
•
•
•
•
•
Mechanism
Inhibits enzyme – DHFR
DHFR = dihydrofolate reductase
Folate-> dihydrofolate->tetrahydrofolate->
DHFR-> DNA synthesis
Bacteriostatic
Spectrum: E Coli+ most urinary pathogens
Narrow spectrum (inactive against anaerobes)
1st line UTI
oral
Antibiotic Resistance
•
•
•
Innate Acquired
3 main biochemical mechanisms of
acquired resistance
a)  bacterial permeability to an antibiotic
b) Bacterial enzymes
c) Altered target site for antibiotic
Revision Mechanisms
•
•
•
•
Inhibition of cell wall synthesis
Inhibition of bacterial protein synthesis
Inhibition of bacterial DNA synthesis
Inhibition of metabolic pathway (e.g.folate)
synthesis
1) Inhibition of cell wall synthesis
•
1)
2)
3)
Beta Lactams – 3 major classes
Penicillins
Cephalosporins
Carbapenems
1) Inhibition of cell wall synthesis
• No cell wall in mammals/present in
bacteria
• Peptidoglycan
• Beta lactam ring
• Bactericidal
• High therapeutic index
• Mainly excreted in kidney
• Safe in pregnancy
2) Inhibition of bacterial protein
synthesis
• Inhibition of ribosomal protein synthesis
• Formation of amino acids:
• Gene transcription-> messengerRNA->
ribosomes-> translation-> amino acids->proteins
• Antibiotics bind to bacterial ribosome
• Selective toxicity
• Ususally bacteriostatic but aminoglycosidescidal
• Macrolides, aminoglycosides, tetracyclines,
3) Inhibition of bacterial DNA synthesis
• Bactricidal
• Selective toxicity – mammals do not
contain DNA gyrase
• Quinolones, metronidazole,
• Quinolones: Inhibit DNA gyrase, DNA
gyrase is responsible for forming DNA
supercoils for replication and repair.
4) Inhibition of folate synthesis
•
•
•
•
•
•
•
DNA requires folate
Folate-> tetrahydrofolate-> DNA
Inibition of enzyme DHFR(DHF->THF_
E.g. trimethoprim
DHFR= dihydrofolate reductase
DHF = dihydrofolate
THF = tetrahydro folate
This work was produced as part of the TIGER project and funded by JISC and
the HEA in 2011. For further information see:
http://www.northampton.ac.uk/tiger.
This work by TIGER Project is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License. Based on a
work at tiger.library.dmu.ac.uk.
The TIGER project has sought to ensure content of the materials comply with
a CC BY NC SA licence. Some material links to third party sites and may use
a different licence, please check before using. The TIGER project nor any of
its partners endorse these sites and cannot be held responsible for their
content. Any logos or trademarks in the resource are exclusive property of
their owners and their appearance is not an endorsement by the TIGER
project.